57
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The application of clinical variables and models to predict pulmonary embolism in cancer patients: a comprehensive single cancer center experience

, , , , &
Pages 1111-1116 | Published online: 23 Oct 2013

References

  • HorlanderKTManninoDMLeeperKVPulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality dataArch Intern Med2003163141711171712885687
  • LymanGHKhoranaAAKudererNMLeeAYCancer and thrombosis: back to the future renewed interest in an old problemCancer Invest200927547247319479483
  • HeitJAO’FallonWMPettersonTMRelative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based studyArch Intern Med2002162111245124812038942
  • ThodiyilPAKakkarAKVariation in relative risk of venous thromboembolism in different cancersThromb Haemost20028761076107712083490
  • GoldhaberSZHennekensCHEvansDANewtonECGodleskiJJFactors associated with correct antemortem diagnosis of major pulmonary embolismAm J Med19827368228267148876
  • LucassenWGeersingGJErkensPMClinical decision rules for excluding pulmonary embolism: a meta-analysisAnn Intern Med2011155744846021969343
  • SteinPDBeemathAMattaFClinical characteristics of patients with acute pulmonary embolism: data from PIOPED IIAm J Med20071201087187917904458
  • Le GalGTestuzARighiniMBounameauxHPerrierAReproduction of chest pain by palpation: diagnostic accuracy in suspected pulmonary embolismBMJ2005330748945245315684025
  • SteinPDWoodardPKWegJGPIOPED II InvestigatorsDiagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II InvestigatorsRadiology20072421152117185658
  • PrandoniPLensingAWBüllerHRDeep-vein thrombosis and the incidence of subsequent symptomatic cancerN Engl J Med199232716112811331528208
  • HeitJASilversteinMDMohrDNPettersonTMO’FallonWMMeltonLJIIIRisk factors for deep vein thrombosis and pulmonary embolism: a population based case-control studyArch Intern Med2000160680981510737280
  • CarsonJLKelleyMADuffAThe clinical course of pulmonary embolismN Engl J Med199232619124012451560799
  • PengoVLensingAWPrinsMHThromboembolic Pulmonary Hypertension Study GroupIncidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismN Engl J Med2004350222257226415163775
  • SørensenHTMellemkjaerLOlsenJHBaronJAPrognosis of cancers associated with venous thromboembolismN Engl J Med2000343251846185011117976
  • SallahSWanJYNguyenNPVenous thrombosis in patients with solid tumors: determination of frequency and characteristicsThromb Haemost200287457557912008937
  • ChewHKWunTHarveyDZhouHWhiteRHIncidence of venous thromboembolism and its effect on survival among patients with common cancersArch Intern Med2006166445846416505267
  • MarrasLCGeertsWHPerryJRThe risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based reviewCancer200089364064610931464
  • AndtbackaRHBabieraGSingletarySEIncidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathwaysAnn Surg200624319610116371742
  • ChewHKWunTHarveyDJZhouHWhiteRHIncidence of venous thromboembolism and the impact on survival in breast cancer patientsJ Clin Oncol2007251707617194906
  • BlomJWDoggenCJOsantoSRosendaalFRMalignancies, prothrombotic mutations, and risk of venous thrombosisJAMA2005293671572215701913
  • HaddadTCGreenoEWChemotherapy-induced thrombosisThromb Res2006118555556816388837
  • FisherBCostantinoJPWickerhamDLTamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1studyJ Natl Cancer Inst200597221652166216288118
  • PritchardKIPatersonAHPaulNAZeeBFineSPaterJIncreased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with metastatic breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site GroupJ Clin Oncol19961410273127378874334
  • ZangariMSiegelEBarlogieBThrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapyBlood200210041168117112149193
  • WellsPSAndersonDRRodgerMExcluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimerAnn Intern Med200113529810711453709
  • HallWBTruittSGScheunemannLPThe prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolismArch Intern Med2009169211961196519933956
  • SteinPDFowlerSEGoodmanLRPIOPED II InvestigatorsMultidetector computed tomography for acute pulmonary embolismN Engl J Med2006354222317232716738268
  • TsaiKLGuptaEHaramatiLBPulmonary atelectasis: a frequent alternative diagnosis in patients undergoing CT-PA for suspected pulmonary embolismEmerg Radiol200410528228615290480
  • LombardJBhatiaRSalaESpiral computed tomographic pulmonary angiography for investigating suspected pulmonary embolism: clinical outcomesCan Assoc Radiol J200354314715112866238
  • KhoranaAAKudererNMCulakovaELymanGHFrancisCWDevelopment and validation of a predictive model for chemotherapy-associated thrombosisBlood2008111104902490718216292
  • AyCSimanekRVormittagRHigh plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)Blood200811272703270818539899
  • AyCVormittagRDunklerDD-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJ Clin Oncol200927254124412919636003